CohBar, Inc. to Announce Fourth Quarter 2016 Financial Results and Host Conference Call for Shareholders on March 22, 2017
MENLO PARK, Calif.--(BUSINESS WIRE)-- CohBar, Inc. (OTCQX: CWBR and TSXV: COB.U), a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced today that the Company will release its fourth quarter 2016 financial results on Wednesday, March 22, 2017 and management will host a conference call for shareholders the same day at 2:00 p.m. (PST).
Conference Call Information:
Date: March 22, 2017
Time: 2:00
p.m. (PST)
Dial-in U.S. and Canada: 1-888-287-5516
Dial-in
International: 1-719-457-2683
Conference ID# 3409008
An audio recording of the call will be available beginning at 5:00 p.m. (PST) on March 22, 2017, through 9:00 p.m. (PDT) on March 29, 2017. To access the recording please dial 1-844-512-2921 in the U.S. and Canada or 1-412-317-6671 internationally and reference Conference ID# 3409008.
About CohBar
CohBar (OTCQX: CWBR and TSXV: COB.U) is a
preclinical stage biotechnology company focused on the research and
development of mitochondria based therapeutics (MBTs), an emerging class
of drugs for the treatment of age-related diseases. MBTs originate from
the discovery by CohBar’s founders of a novel group of peptides within
the mitochondrial genome, which regulate metabolism and cell death and
whose biological activity declines with age. CohBar’s efforts focus on
the development of these mitochondrial-derived peptides (MDPs) into
clinically relevant MBTs that offer the potential to address a broad
range of age-related diseases, including obesity, fatty liver disease
(NASH), Type-2 diabetes, cancer, cardiovascular and neurodegenerative
diseases. To date, the Company and its founders have discovered more
than 50 biologically active mitochondrial peptides.
For additional company information, please visit www.cohbar.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170303005494/en/
CohBar, Inc.
Anna Schram, 650-446-7888 ext. 114
anna.schram@cohbar.com
Source: CohBar, Inc.
Released March 3, 2017